Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial

AIMS: Various beta-blockers with distinct pharmacological profiles are approved in heart failure, yet they remain underused and underdosed. Although potentially of major public health importance, whether one agent is superior in terms of tolerability and optimal dosing has not been investigated. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Düngen, Hans-Dirk, Apostolović, Svetlana, Inkrot, Simone, Tahirović, Elvis, Töpper, Agnieszka, Mehrhof, Felix, Prettin, Christiane, Putniković, Biljana, Nešković, Aleksandar N., Krotin, Mirjana, Sakač, Dejan, Lainščak, Mitja, Edelmann, Frank, Wachter, Rolf, Rau, Thomas, Eschenhagen, Thomas, Doehner, Wolfram, Anker, Stefan D., Waagstein, Finn, Herrmann-Lingen, Christoph, Gelbrich, Goetz, Dietz, Rainer
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101867/
https://www.ncbi.nlm.nih.gov/pubmed/21429992
http://dx.doi.org/10.1093/eurjhf/hfr020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101867/
https://www.ncbi.nlm.nih.gov/pubmed/21429992
http://dx.doi.org/10.1093/eurjhf/hfr020

Ejemplares similares